default image

Urologie

Information and services of the department

  • Number of inpatient cases: 78

Services search (in the department)


Illness Number of cases
Malignant neoplasm of bladder - Malignant neoplasm of bladder unspecified (C67.9) 19
Calculus of kidney and ureter - Calculus of ureter (N20.1) 11
Hyperplasia of prostate (N40) 10
Neoplasm of uncertain or unknown behaviour of urinary organs - Neoplasm of uncertain behavior of bladder (D41.4) 6
Benign neoplasm of urinary organs - Benign neoplasm of bladder (D30.3) 4
Malignant neoplasm of prostate (C61) not specified
Malignant neoplasm of testis (C62.9) not specified
Malignant neoplasm of bladder - Malignant neoplasm of trigone of bladder (C67.0) not specified
Malignant neoplasm of bladder - Malignant neoplasm of overlapping sites of bladder (C67.8) not specified
Malignant neoplasm of other and unspecified urinary organs - Malignant neoplasm of urinary organ unspecified (C68.9) not specified
Treatment Number
Examination of the urethra and the urinary bladder by endoscopy (1-661) 70
Injection or administration of medicines into the urinary bladder (8-132.3) 58
Surgical incision, removal or destruction of diseased tissue in the urinary bladder, with access through the urethra (5-573.40) 46
X-rays of the kidney and urinary tract with contrast medium (3-13d.5) 13
Surgical removal or destruction of prostatic tissue through the urethra (5-601.0) 13
Insertion, exchange or removal of a ureteral stent (8-137.00) 13
Dilatation of the ureters during an operation or endoscopy (5-560.2) 12
Examination of the ureter by endoscopy (1-665) 4
Surgical incision into the ureter or removal of a stone during an open operation or endoscopy (5-562.8) 4
Surgical incision into the ureter or removal of a stone during an open operation or endoscopy (5-562.9) 4

Hospital information and services for all specialist departments

External comparative quality assurance
Further information
  • External quality assurance according to state law
    No participation
  • Quality of participation in the Disease Management Programme (DMP)
    No participation
No. Explanation
CQ07 Weiterführende standortbezogene Informationen unter: www.perinatalzentren.org
Number Group
79 Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
59 Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
34 Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations
* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”
Job Explanation
Student training (clinical traineeship / internship year)
No. Training in other healing professions Comment
HB19 Nursing professionals
HB17 Auxiliary nurse (m/f)

Frau Katharina Mentz

Qualitätsmanagement

Phone: 04251 -787-1341
Mail: ed.soema@ztnem.anirahtak

Frau Maren Eggeling

Ltg. Qualitätsmanagement

Phone: 04521 -787-0
Mail: ed.soema@nitue.ofni

Prof. Dr. med. Markus Quante

Ärztlicher Direktor, Chefarzt Wirbelsäulenchirurgie mit Skoliosezentrum

Phone: 04521 -787-2360
Mail: ed.soema@etnauq.sukram

Dr. Iris Koper

Chefärztin Innere Medizin, Schwerpunkt Pneumologie, Fachärztin für Intensivmedizin, Schlafmedizin, Allergologie und Umweltmedizin

Phone: 04361 -513-140
Mail: ed.soema@repok.siri